Aroa Biosurgery Statistics

Total Valuation

Aroa Biosurgery has a market cap or net worth of 130.37 million. The enterprise value is 120.97 million.

Market Cap	130.37M
Enterprise Value	120.97M

Important Dates

The last earnings date was Monday, June 30, 2025.

Earnings Date	Jun 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	344.90M
Shares Outstanding	n/a
Shares Change (YoY)	+0.31%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	259.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	97.23
PS Ratio	2.72
PB Ratio	2.47
P/TBV Ratio	2.93
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 149.52, with an EV/FCF ratio of -43.79.

EV / Earnings	-55.98
EV / Sales	2.39
EV / EBITDA	149.52
EV / EBIT	n/a
EV / FCF	-43.79

Financial Position

The company has a current ratio of 6.62, with a Debt / Equity ratio of 0.07.

Current Ratio	6.62
Quick Ratio	5.58
Debt / Equity	0.07
Debt / EBITDA	4.74
Debt / FCF	-1.32
Interest Coverage	-6.13

Financial Efficiency

Return on equity (ROE) is -4.06% and return on invested capital (ROIC) is -1.81%.

Return on Equity (ROE)	-4.06%
Return on Assets (ROA)	-1.66%
Return on Invested Capital (ROIC)	-1.81%
Return on Capital Employed (ROCE)	-2.96%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.77
Inventory Turnover	1.48

Taxes

In the past 12 months, Aroa Biosurgery has paid 319,071 in taxes.

Income Tax	319,071
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.32
200-Day Moving Average	n/a
Relative Strength Index (RSI)	82.36
Average Volume (20 Days)	878

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aroa Biosurgery had revenue of 48.00 million and -2.16 million in losses. Loss per share was -0.01.

Revenue	48.00M
Gross Profit	41.15M
Operating Income	-1.65M
Pretax Income	-1.84M
Net Income	-2.16M
EBITDA	144,517
EBIT	-1.65M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 12.55 million in cash and 3.64 million in debt, giving a net cash position of 8.92 million.

Cash & Cash Equivalents	12.55M
Total Debt	3.64M
Net Cash	8.92M
Net Cash Per Share	n/a
Equity (Book Value)	52.75M
Book Value Per Share	0.15
Working Capital	32.80M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.45 million and capital expenditures -1.31 million, giving a free cash flow of -2.76 million.

Operating Cash Flow	-1.45M
Capital Expenditures	-1.31M
Free Cash Flow	-2.76M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 85.73%, with operating and profit margins of -3.45% and -4.50%.

Gross Margin	85.73%
Operating Margin	-3.45%
Pretax Margin	-3.84%
Profit Margin	-4.50%
EBITDA Margin	0.30%
EBIT Margin	-3.45%
FCF Margin	n/a

Dividends & Yields

Aroa Biosurgery does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.31%
Shareholder Yield	n/a
Earnings Yield	-1.66%
FCF Yield	-2.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aroa Biosurgery has an Altman Z-Score of 8.87 and a Piotroski F-Score of 3.

Altman Z-Score	8.87
Piotroski F-Score	3